Completed NA INTERVENTIONAL 1-arm NCT05605691

Post-Market Lower Eyelid Treatment With Renuvion in Greece

A Post-Market Study In Greece Of A Minimally Invasive Lower Eyelid Treatment Utilizing The Renuvion System

Sponsor: Apyx Medical

Updated 7 times since 2022 Last updated: Mar 24, 2025 Started: Oct 11, 2022 Primary completion: Mar 5, 2024 Completion: Mar 5, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05605691, this NA trial focuses on Skin Laxity and remains completed. Sponsored by Apyx Medical, it has been updated 7 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Apr 2025 — Present [monthly]

Completed NA
Sep 2024 — Apr 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2024 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2024 — May 2024 [monthly]

Active Not Recruiting NA

▶ Show 2 earlier versions

Oct 2023 — Jan 2024 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Dec 2022 — Oct 2023 [monthly]

Recruiting NA

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Apyx Medical

Data source: Apyx Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, Greece